Rothschild & CO Asset Management Us Inc. Horizon Therapeutics Public LTD CO Transaction History
Rothschild & CO Asset Management Us Inc.
- $6.56 Billion
- Q4 2022
A detailed history of Rothschild & CO Asset Management Us Inc. transactions in Horizon Therapeutics Public LTD CO stock. As of the latest transaction made, Rothschild & CO Asset Management Us Inc. holds 403,734 shares of HZNP stock, worth $0. This represents 0.7% of its overall portfolio holdings.
Number of Shares
403,734
Previous 428,706
5.82%
Holding current value
$0
Previous $26.5 Million
73.16%
% of portfolio
0.7%
Previous 0.45%
Shares
15 transactions
Others Institutions Holding HZNP
# of Institutions
38Shares Held
2.07MCall Options Held
0Put Options Held
20K-
Pictet Asset Management Sa Geneva 73, V8735KShares$00.09% of portfolio
-
Jefferies Group LLC New York, NY237KShares$00.14% of portfolio
-
Ergoteles LLC New York, NY122KShares$020.67% of portfolio
-
Regent Investment Management LLC101KShares$03.09% of portfolio
-
Berry Street Capital Management LLP London, X087.5KShares$02.97% of portfolio
About Horizon Therapeutics Public Ltd Co
- Ticker HZNP
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 230,384,000
- Description
- Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...